# EDGAR Filing Document

**Accession Number:** 0000898031
**File Stem:** 0001410368-26-068158
**Filing Date:** 2026-6
**Character Count:** 26398
**Document Hash:** 30c7a47bef2be40eda1c47bf280e3efa
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001410368-26-068158.hdr.sgml**: 20260629

**ACCESSION NUMBER**: 0001410368-26-068158

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260430

**FILED AS OF DATE**: 20260629

**DATE AS OF CHANGE**: 20260629

**PERIOD START**: 20261031

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** LORD ABBETT SECURITIES TRUST
- **CENTRAL INDEX KEY:** 0000898031

**ORGANIZATION NAME:**
- **EIN:** 133712440
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1031

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-07538
- **FILM NUMBER:** 261132415

**BUSINESS ADDRESS:**
- **STREET 1:** 30 HUDSON STREET
- **CITY:** JERSEY CITY
- **STATE:** NJ
- **ZIP:** 07302
- **BUSINESS PHONE:** 201-827-2000

**MAIL ADDRESS:**
- **STREET 1:** 30 HUDSON STREET
- **CITY:** JERSEY CITY
- **STATE:** NJ
- **ZIP:** 07302

## Series and Classes Contracts Data

### Lord Abbett Health Care Fund (Series ID: S000064462)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000208658 | Class A      | LHCAX           |
| C000208659 | Class C      | LHCCX           |
| C000208660 | Class F      | LHCFX           |
| C000208661 | Class F3     | LHCOX           |
| C000208662 | Class I      | LHCIX           |
| C000208664 | Class R3     | LHCQX           |
| C000208665 | Class R4     | LHCSX           |
| C000208666 | Class R6     | LHCVX           |
| C000208667 | Class R5     | LHCTX           |

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** LORD ABBETT SECURITIES TRUST

- **b. Investment Company Act file number:** 811-07538

- **c. CIK number of Registrant:** 0000898031

- **d. LEI of Registrant:** 5493002HV0D15KTWO412

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 30 HUDSON STREET

  - **City:** JERSEY CITY

  - **State:** NJ

  - **Foreign country:** US

  - **Zip / Postal Code:** 07302

  - **Telephone number:** 201-827-2000

**Item A.2. Information about the Series.**

- **a. Name of Series:** Lord Abbett Health Care Fund

- **b. EDGAR series identifier (if any):** S000064462

- **c. LEI of Series:** 549300KZ8HTJO03UM174

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2026-10-31

- **b. Date as of which information is reported:** 2026-04-30

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $8324385.30

**Total Liabilities:** $178849.57

**Net Assets:** $8145535.73

**Cash Not Reported:** $322.84

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000208667 | 0.89%                | -4.60%               | 0.28%                |
| Class ID C000208664 | 0.87%                | -4.63%               | 0.24%                |
| Class ID C000208659 | 0.80%                | -4.64%               | 0.15%                |
| Class ID C000208665 | 0.86%                | -4.60%               | 0.23%                |
| Class ID C000208660 | 0.89%                | -4.58%               | 0.23%                |
| Class ID C000208658 | 0.86%                | -4.60%               | 0.23%                |
| Class ID C000208662 | 0.89%                | -4.59%               | 0.23%                |
| Class ID C000208661 | 0.93%                | -4.62%               | 0.28%                |
| Class ID C000208666 | 0.89%                | -4.57%               | 0.23%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $-21402.03               | $98320.76                                  |
| Month 2  | $127291.40               | $-523087.21                                |
| Month 3  | $93891.39                | $-70370.42                                 |

### Schedule of Portfolio Investments

| Name                               | Title                                                  | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| 10X Genomics Inc                   | 10X Genomics Inc                                       | CUSIP: 88025U109<br>LEI: 5493003Z6741WNLG7H43 | Long             | EC               | CORP              | US        |      3200 | NS      | $70560.00     | 0.87%             |  |  |  | No            |                  1 | On Loan: No      |
| Galderma Group AG                  | Galderma Group AG                                      | CUSIP: 000000000<br>LEI: 89450001OK6O8ELQ4584 | Long             | EC               | CORP              | CH        |       818 | NS      | $171610.96    | 2.11%             |  |  |  | No            |                  2 | On Loan: No      |
| Arrowhead Pharmaceuticals Inc      | Arrowhead Pharmaceuticals Inc                          | CUSIP: 04280A100<br>LEI: 549300O3CSB8T7OZ3D66 | Long             | EC               | CORP              | US        |       962 | NS      | $70687.76     | 0.87%             |  |  |  | No            |                  1 | On Loan: No      |
| Protagonist Therapeutics Inc       | Protagonist Therapeutics Inc                           | CUSIP: 74366E102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       580 | NS      | $57402.60     | 0.70%             |  |  |  | No            |                  1 | On Loan: No      |
| Rhythm Pharmaceuticals Inc         | Rhythm Pharmaceuticals Inc                             | CUSIP: 76243J105<br>LEI: 529900JPNWXQ8DPLA551 | Long             | EC               | CORP              | US        |       942 | NS      | $76641.12     | 0.94%             |  |  |  | No            |                  1 | On Loan: No      |
| DBV Technologies SA                | DBV Technologies SA                                    | CUSIP: 23306J309<br>LEI: 969500PVBQFWQKVDMD80 | Long             | EC               | CORP              | FR        |      2973 | NS      | $62433.00     | 0.77%             |  |  |  | No            |                  1 | On Loan: No      |
| Newamsterdam Pharma Co NV          | Newamsterdam Pharma Co NV                              | CUSIP: 000000000<br>LEI: 984500B6549TF6E14D36 | Long             | EC               | CORP              | NL        |      1944 | NS      | $55520.64     | 0.68%             |  |  |  | No            |                  1 | On Loan: No      |
| Argenx SE                          | Argenx SE                                              | CUSIP: 000000000<br>LEI: 7245009C5FZE6G9ODQ71 | Long             | EC               | CORP              | NL        |       259 | NS      | $203114.97    | 2.49%             |  |  |  | No            |                  2 | On Loan: No      |
| Vertex Pharmaceuticals Inc         | Vertex Pharmaceuticals Inc                             | CUSIP: 92532F100<br>LEI: 54930015RAQRRZ5ZGJ91 | Long             | EC               | CORP              | US        |       311 | NS      | $132915.18    | 1.63%             |  |  |  | No            |                  1 | On Loan: No      |
| Johnson & Johnson                  | Johnson & Johnson                                      | CUSIP: 478160104<br>LEI: 549300G0CFPGEF6X2043 | Long             | EC               | CORP              | US        |      1129 | NS      | $259500.65    | 3.19%             |  |  |  | No            |                  1 | On Loan: No      |
| UnitedHealth Group Inc             | UnitedHealth Group Inc                                 | CUSIP: 91324P102<br>LEI: 549300GHBMY8T5GXDE41 | Long             | EC               | CORP              | US        |       461 | NS      | $170791.28    | 2.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Repligen Corp                      | Repligen Corp                                          | CUSIP: 759916109<br>LEI: 54930006QJ0T5AUO1E71 | Long             | EC               | CORP              | US        |       425 | NS      | $50281.75     | 0.62%             |  |  |  | No            |                  1 | On Loan: No      |
| Ascendis Pharma A/S                | Ascendis Pharma A/S                                    | CUSIP: 000000000<br>LEI: 549300B66JN3W3J8GH73 | Long             | EC               | CORP              | DK        |       698 | NS      | $160107.24    | 1.97%             |  |  |  | No            |                  1 | On Loan: —       |
| Thermo Fisher Scientific Inc       | Thermo Fisher Scientific Inc                           | CUSIP: 883556102<br>LEI: HCHV7422L5HDJZCRFL38 | Long             | EC               | CORP              | US        |       252 | NS      | $120697.92    | 1.48%             |  |  |  | No            |                  1 | On Loan: No      |
| Oruka Therapeutics Inc             | Oruka Therapeutics Inc                                 | CUSIP: 687604108<br>LEI: 529900TG7O4ESUDMGI54 | Long             | EC               | CORP              | US        |       603 | NS      | $41251.23     | 0.51%             |  |  |  | No            |                  1 | On Loan: No      |
| Mineralys Therapeutics Inc         | Mineralys Therapeutics Inc                             | CUSIP: 603170101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      3220 | NS      | $85813.00     | 1.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Adaptive Biotechnologies Corp      | Adaptive Biotechnologies Corp                          | CUSIP: 00650F109<br>LEI: 549300ZTF7OT1FW66Q96 | Long             | EC               | CORP              | US        |      6769 | NS      | $95442.90     | 1.17%             |  |  |  | No            |                  1 | On Loan: No      |
| HeartFlow Inc                      | HeartFlow Inc                                          | CUSIP: 42238D107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      2360 | NS      | $70233.60     | 0.86%             |  |  |  | No            |                  1 | On Loan: No      |
| Otsuka Holdings Co Ltd             | Otsuka Holdings Co Ltd                                 | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | JP        |      1162 | NS      | $84689.07     | 1.04%             |  |  |  | No            |                  2 | On Loan: No      |
| Madrigal Pharmaceuticals Inc       | Madrigal Pharmaceuticals Inc                           | CUSIP: 558868105<br>LEI: 549300CHIMT2EUSNJB60 | Long             | EC               | CORP              | US        |       350 | NS      | $181086.50    | 2.22%             |  |  |  | No            |                  1 | On Loan: No      |
| United Therapeutics Corp           | United Therapeutics Corp                               | CUSIP: 91307C102<br>LEI: 5299005C4HZL4UWROC14 | Long             | EC               | CORP              | US        |       234 | NS      | $133695.90    | 1.64%             |  |  |  | No            |                  1 | On Loan: No      |
| Revolution Medicines Inc           | Revolution Medicines Inc                               | CUSIP: 76155X100<br>LEI: 549300JU3X0LBCQ65892 | Long             | EC               | CORP              | US        |       764 | NS      | $110107.68    | 1.35%             |  |  |  | No            |                  1 | On Loan: No      |
| Stryker Corp                       | Stryker Corp                                           | CUSIP: 863667101<br>LEI: 5493002F0SC4JTBU5137 | Long             | EC               | CORP              | US        |       186 | NS      | $58614.18     | 0.72%             |  |  |  | No            |                  1 | On Loan: No      |
| ORIC Pharmaceuticals Inc           | ORIC Pharmaceuticals Inc                               | CUSIP: 68622P109<br>LEI: 54930033FJRNEYBW0L25 | Long             | EC               | CORP              | US        |      3130 | NS      | $30924.40     | 0.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Alumis Inc                         | Alumis Inc                                             | CUSIP: 022307102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      2183 | NS      | $53898.27     | 0.66%             |  |  |  | No            |                  1 | On Loan: No      |
| Dianthus Therapeutics Inc          | Dianthus Therapeutics Inc                              | CUSIP: 252828108<br>LEI: 549300Z3N6ODPCOFC890 | Long             | EC               | CORP              | US        |      1575 | NS      | $138285.00    | 1.70%             |  |  |  | No            |                  1 | On Loan: No      |
| CVS Health Corp                    | CVS Health Corp                                        | CUSIP: 126650100<br>LEI: 549300EJG376EN5NQE29 | Long             | EC               | CORP              | US        |      2320 | NS      | $193232.80    | 2.37%             |  |  |  | No            |                  1 | On Loan: No      |
| BeOne Medicines Ltd                | BeOne Medicines Ltd                                    | CUSIP: 000000000<br>LEI: 549300JFUK6FRD5MH739 | Long             | EC               | CORP              | CH        |      3387 | NS      | $76882.08     | 0.94%             |  |  |  | No            |                  2 | On Loan: No      |
| TransMedics Group Inc              | TransMedics Group Inc                                  | CUSIP: 89377M109<br>LEI: 549300060GVOSMWARH50 | Long             | EC               | CORP              | US        |       650 | NS      | $65513.50     | 0.80%             |  |  |  | No            |                  1 | On Loan: No      |
| Tarsus Pharmaceuticals Inc         | Tarsus Pharmaceuticals Inc                             | CUSIP: 87650L103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      3622 | NS      | $230395.42    | 2.83%             |  |  |  | No            |                  1 | On Loan: No      |
| Guardant Health Inc                | Guardant Health Inc                                    | CUSIP: 40131M109<br>LEI: 254900M8C3E5VC8BR186 | Long             | EC               | CORP              | US        |      2459 | NS      | $214129.72    | 2.63%             |  |  |  | No            |                  1 | On Loan: No      |
| Fidelity Investments               | Fidelity Investments Money Market Government Portfolio | CUSIP: 31607A703<br>LEI: E57ODZWZ7FF32TWEFA76 | Long             | STIV             | RF                | US        |    139928 | NS      | $139927.50    | 1.72%             |  |  |  | No            |                  1 | On Loan: No      |
| Samsung Biologics Co Ltd           | Samsung Biologics Co Ltd                               | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | KR        |        51 | NS      | $50848.99     | 0.62%             |  |  |  | Yes           |                  2 | On Loan: No      |
| GeneDx Holdings Corp               | GeneDx Holdings Corp                                   | CUSIP: 81663L200<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      1046 | NS      | $65782.94     | 0.81%             |  |  |  | No            |                  1 | On Loan: No      |
| AstraZeneca PLC                    | AstraZeneca PLC                                        | CUSIP: 000000000<br>LEI: PY6ZZQWO2IZFZC3IOL08 | Long             | EC               | CORP              | GB        |      2029 | NS      | $384946.37    | 4.73%             |  |  |  | No            |                  2 | On Loan: No      |
| Intuitive Surgical Inc             | Intuitive Surgical Inc                                 | CUSIP: 46120E602<br>LEI: 54930052SRG011710797 | Long             | EC               | CORP              | US        |       393 | NS      | $179840.73    | 2.21%             |  |  |  | No            |                  1 | On Loan: No      |
| Fixed Income Clearing Corp.        | FIXED INC CLEARING CORP.REPO                           | CUSIP: 000000000<br>LEI: 549300H47WTHXPU08X20 | Long             | RA               | CORP              | US        |    144818 | PA      | $144817.78    | 1.78%             |  |  |  | No            |                  2 | On Loan: No      |
| Citibank NA                        | CITIBANK NA DDCA                                       | CUSIP: 000000000<br>LEI: E57ODZWZ7FF32TWEFA76 | Long             | STIV             | RF                | US        |     15548 | NS      | $15547.50     | 0.19%             |  |  |  | No            |                  1 | On Loan: No      |
| Bridgebio Pharma Inc               | Bridgebio Pharma Inc                                   | CUSIP: 10806X102<br>LEI: 54930028YG89VTY2J114 | Long             | EC               | CORP              | US        |      2278 | NS      | $161988.58    | 1.99%             |  |  |  | No            |                  1 | On Loan: No      |
| Nuvalent Inc                       | Nuvalent Inc                                           | CUSIP: 670703107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       520 | NS      | $52145.60     | 0.64%             |  |  |  | No            |                  1 | On Loan: No      |
| Argenx SE                          | Argenx SE                                              | CUSIP: 000000000<br>LEI: 7245009C5FZE6G9ODQ71 | Long             | EC               | CORP              | NL        |         7 | NS      | $5487.99      | 0.07%             |  |  |  | No            |                  2 | On Loan: No      |
| UCB SA                             | UCB SA                                                 | CUSIP: 000000000<br>LEI: 2138008J191VLSGY5A09 | Long             | EC               | CORP              | BE        |       522 | NS      | $142136.05    | 1.74%             |  |  |  | No            |                  2 | On Loan: No      |
| Edwards Lifesciences Corp          | Edwards Lifesciences Corp                              | CUSIP: 28176E108<br>LEI: YA13X31F3V31L8TMPR58 | Long             | EC               | CORP              | US        |      1775 | NS      | $148212.50    | 1.82%             |  |  |  | No            |                  1 | On Loan: No      |
| Apogee Therapeutics Inc            | Apogee Therapeutics Inc                                | CUSIP: 03770N101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       487 | NS      | $40367.43     | 0.50%             |  |  |  | No            |                  1 | On Loan: No      |
| Cencora Inc                        | Cencora Inc                                            | CUSIP: 03073E105<br>LEI: AI8GXW8LG5WK7E9UD086 | Long             | EC               | CORP              | US        |       525 | NS      | $161705.25    | 1.99%             |  |  |  | No            |                  1 | On Loan: No      |
| Insmed Inc                         | Insmed Inc                                             | CUSIP: 457669307<br>LEI: 529900Q55QAG41CCAC11 | Long             | EC               | CORP              | US        |       630 | NS      | $85887.90     | 1.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Celcuity Inc                       | Celcuity Inc                                           | CUSIP: 15102K100<br>LEI: 25490070W7UU7W2SEY87 | Long             | EC               | CORP              | US        |      1349 | NS      | $163701.15    | 2.01%             |  |  |  | No            |                  1 | On Loan: No      |
| RadNet Inc                         | RadNet Inc                                             | CUSIP: 750491102<br>LEI: 529900RECG94V2IZJ970 | Long             | EC               | CORP              | US        |       672 | NS      | $38001.60     | 0.47%             |  |  |  | No            |                  1 | On Loan: No      |
| Abivax SA                          | Abivax SA                                              | CUSIP: 00370M103<br>LEI: 969500D8TMNB184OJU95 | Long             | EC               | CORP              | FR        |      1296 | NS      | $152124.48    | 1.87%             |  |  |  | No            |                  1 | On Loan: No      |
| Nektar Therapeutics                | Nektar Therapeutics                                    | CUSIP: 640268306<br>LEI: 5299005I24806IOIYE03 | Long             | EC               | CORP              | US        |      3038 | NS      | $258351.52    | 3.17%             |  |  |  | No            |                  1 | On Loan: No      |
| Cogent Biosciences Inc             | Cogent Biosciences Inc                                 | CUSIP: 19240Q201<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      4983 | NS      | $178341.57    | 2.19%             |  |  |  | No            |                  1 | On Loan: No      |
| Natera Inc                         | Natera Inc                                             | CUSIP: 632307104<br>LEI: 529900CQ3OZ0A0VYVU59 | Long             | EC               | CORP              | US        |      1151 | NS      | $237290.16    | 2.91%             |  |  |  | No            |                  1 | On Loan: No      |
| CG oncology Inc                    | CG oncology Inc                                        | CUSIP: 156944100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      1223 | NS      | $81623.02     | 1.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Glaukos Corp                       | Glaukos Corp                                           | CUSIP: 377322102<br>LEI: 5299004JA1LHE21M6T14 | Long             | EC               | CORP              | US        |       526 | NS      | $75570.42     | 0.93%             |  |  |  | No            |                  1 | On Loan: No      |
| Novartis AG                        | Novartis AG                                            | CUSIP: 000000000<br>LEI: 5493007HIVTX6SY6XD66 | Long             | EC               | CORP              | CH        |      1356 | NS      | $200402.79    | 2.46%             |  |  |  | No            |                  2 | On Loan: No      |
| Encompass Health Corp              | Encompass Health Corp                                  | CUSIP: 29261A100<br>LEI: 549300FVRPM9DRQZRG64 | Long             | EC               | CORP              | US        |       677 | NS      | $67700.00     | 0.83%             |  |  |  | No            |                  1 | On Loan: No      |
| Teva Pharmaceutical Industries Ltd | Teva Pharmaceutical Industries Ltd                     | CUSIP: 881624209<br>LEI: 549300BAFGM4RC74ZJ94 | Long             | EC               | CORP              | IL        |      2957 | NS      | $103701.99    | 1.27%             |  |  |  | No            |                  1 | On Loan: No      |
| Scholar Rock Holding Corp          | Scholar Rock Holding Corp                              | CUSIP: 80706P103<br>LEI: 549300Z1FLPGL4OWJ459 | Long             | EC               | CORP              | US        |       822 | NS      | $38313.42     | 0.47%             |  |  |  | No            |                  1 | On Loan: No      |
| PTC Therapeutics Inc               | PTC Therapeutics Inc                                   | CUSIP: 69366J200<br>LEI: 549300UJLWOIWFDGB318 | Long             | EC               | CORP              | US        |      1401 | NS      | $91149.06     | 1.12%             |  |  |  | No            |                  1 | On Loan: No      |
| Eli Lilly & Co                     | Eli Lilly & Co                                         | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |       775 | NS      | $724315.00    | 8.89%             |  |  |  | No            |                  1 | On Loan: No      |
| Mirum Pharmaceuticals Inc          | Mirum Pharmaceuticals Inc                              | CUSIP: 604749101<br>LEI: 254900YZKR40F7F27K81 | Long             | EC               | CORP              | US        |      1467 | NS      | $142753.77    | 1.75%             |  |  |  | No            |                  1 | On Loan: No      |
| Roivant Sciences Ltd               | Roivant Sciences Ltd                                   | CUSIP: 000000000<br>LEI: 549300DL466NY5J6U724 | Long             | EC               | CORP              | BM        |      1451 | NS      | $41397.03     | 0.51%             |  |  |  | No            |                  1 | On Loan: No      |
| IDEXX Laboratories Inc             | IDEXX Laboratories Inc                                 | CUSIP: 45168D104<br>LEI: OGMTXK0LUU1HKV2P0J84 | Long             | EC               | CORP              | US        |        89 | NS      | $49911.20     | 0.61%             |  |  |  | No            |                  1 | On Loan: No      |
| Gilead Sciences Inc                | Gilead Sciences Inc                                    | CUSIP: 375558103<br>LEI: 549300WTZWR07K8MNV44 | Long             | EC               | CORP              | US        |      2647 | NS      | $346333.48    | 4.25%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2026-05-19

**Name of Applicant:** LORD ABBETT SECURITIES TRUST

**Signature:** Michael Hebert

**Name of Signer:** Michael Hebert

**Title:** Chief Financial Officer